Many Can Avoid RT After Surgery for Localized Prostate Cancer
Progression-free survival no different at five years when radiotherapy is used only if the cancer returns.
Conference News
Hodgkin Lymphoma Diagnosis During Pregnancy Does Not Appear to Affect Maternal Survival
In an assessment of data from the International Network on Cancer registry, researchers determined that maternal 5-year survival for pregnant women with HL was comparable to that of their nonpregnant counterparts.
Therapeutic Drug Monitoring Can Improve Target Exposure Levels of Busulfan Prior to Allogenic Hematopoietic Cell Transplantation
Researchers compared models for determining cumulative exposure of busulfan in adult and pediatric patients receiving the drug prior to allo-HCT.
Durvalumab Still Beneficial Despite Association With Radiation Pneumonitis
A substudy of the PACIFIC trial sought to determine if low-grade pneumonitis associated with durvalumab should deter its use in patients with NSCLC.
Efficacy of IV Ferric Carboxymalotose Similar to Traditional Treatments for Prevention of Chemotherapy-Induced Anemia
Using a subset from the GeparOcto trial, researchers sought to determine if IV FCM was superior to physicians’ choice in treating chemotherapy-induced anemia in patients with breast cancer.
Retrovirally Naïve HIV+ Patients With Non-Hodgkin Lymphoma Can Be Treated With Standard Chemotherapy
Researchers investigated the efficacy and safety of CHOP-like therapy for treatment-naïve patients with simultaneous diagnoses of NHL and HIV-positive.
Young People at the End of Cancer Treatment Face Unique Challenges, Conflicting Emotions
Interviews with young cancer survivors revealed the 3 themes that define their concerns regarding the end of treatment.
Nurse-Led Service Improves Totally Implantable Vascular Device Delivery, Enhances Patient Quality of Life
Results of a novel program in which nurses fully provided services related to TIVADs, replacing use of PICC lines and improving patient quality of life and satisfaction.
Single-Center Study Confirms Scalp Cooling System Can Mitigate Chemotherapy-Induced Alopecia in Women With Breast Cancer
A single-institution study is able to reproduce results of previous studies on the use of a scalp cooling system to prevent chemotherapy-induced hair loss in patients with breast cancer receiving anthracycline and/or taxane-based therapies.
Clinical Benefit, Price of Cancer Drugs in United States and Europe: A Comparison Study
Researchers report on a study comparing the US cost and clinical benefit of recently approved cancer drugs with those in Europe.
